Neuromorphic Electrical Stimulation Systems for Personalized Bone Healing and Pain Management

Publication ID: 24-11857785_0010_PTD

Published: October 28, 2025

Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Neuromorphic Electrical Stimulation Systems for Personalized Bone Healing and Pain Management,” Published Technical Disclosure No. 24-11857785_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857785_0010_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,785.

Summary of the Inventive Concept

This inventive concept discloses next-generation electrical stimulation systems that leverage cognitive computing, digital twins, swarm intelligence, AI-driven platforms, and biohybrid components to revolutionize bone healing and pain management. These systems adapt to individual patient needs, optimize therapeutic outcomes, and offer unprecedented levels of personalization and efficacy.

Background and Problem Solved

The original patent's non-invasive transcutaneous electrical stimulation devices have limitations in terms of adaptability, precision, and efficacy. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a paradigm shift in electrical stimulation therapy, enabling real-time adaptation, precision targeting, and optimal therapeutic outcomes.

Detailed Description of the Inventive Concept

The inventive concept encompasses four key aspects: 1) a neuromorphic stimulation system with cognitive computing, which adapts stimulation protocols based on patient outcomes; 2) a method for personalized electrical stimulation therapy using digital twins and simulation; 3) a wearable, implantable, or transcutaneous device with swarm intelligence, which coordinates stimulation pulses for synchronized electromagnetic fields; and 4) an AI-driven platform with cloud-based analysis and mobile application feedback. The biohybrid electrical stimulation system incorporates genetically engineered living tissue components to enhance bone healing and tissue regeneration.

Novelty and Inventive Step

The new claims introduce unprecedented levels of adaptability, precision, and personalization through the integration of cognitive computing, digital twins, swarm intelligence, AI-driven platforms, and biohybrid components. These innovations overcome the limitations of the original patent, providing a novel and non-obvious approach to electrical stimulation therapy.

Alternative Embodiments and Variations

Alternative embodiments could include the use of edge computing, blockchain, or quantum computing to enhance the system's adaptability and security. Variations may include the application of these technologies to other therapeutic areas, such as wound healing, pain management, or neurological disorders.

Potential Commercial Applications and Market

The inventive concept has vast commercial potential in the medical device industry, particularly in the areas of orthopedics, pain management, and regenerative medicine. The market for electrical stimulation devices is expected to grow significantly, driven by the increasing demand for personalized and effective therapeutic solutions.

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biomedical engineering, specifically electrical stimulation therapy for tissue healing and pain management, requiring advanced knowledge of medical device design, signal processing, and physiological response monitoring

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with expertise in electrical stimulation technologies, signal generation, sensor integration, and adaptive medical device design with advanced degrees and 3-5 years of specialized experience

Obviousness Rationale

A PHOSITA would recognize that the disclosed neuromorphic and AI-driven electrical stimulation systems represent predictable extensions of existing electrical stimulation therapy technologies. The source patent's foundational electrical stimulation system provides a clear technological framework that naturally invites computational and adaptive enhancements. The PTD's variations leverage well-established techniques in machine learning, digital simulation, and personalized medical technology to incrementally improve therapeutic electrical stimulation approaches.

Obvious Combinations & Variations

Source Patent Element

Signal generator configured to generate therapeutic signals for post-surgical interventions

PTD Variation

Cognitive computing module that adapts stimulation protocols based on patient outcome datasets

Obviousness Reasoning

Predictable application of machine learning to optimize existing therapeutic signal generation, representing a known technique for improving medical device performance

Source Patent Element

System with physiological parameter monitoring sensors

PTD Variation

Digital twin simulation platform for predicting and selecting optimal stimulation protocols

Obviousness Reasoning

Logical extension of existing sensor-based monitoring to computational modeling, utilizing standard techniques in medical device design and predictive analytics

Source Patent Element

Housing containing signal generator and energy source

PTD Variation

Wearable device with swarm intelligence for coordinated electromagnetic field generation

Obviousness Reasoning

Straightforward design modification applying known distributed computing principles to existing electrical stimulation device architectures

Source Patent Element

System for tracking patient-reported outcomes and physiological parameters

PTD Variation

Cloud-based AI platform with mobile application for real-time stimulation protocol feedback

Obviousness Reasoning

Conventional integration of digital communication technologies with existing medical monitoring systems, representing an obvious technological progression

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857785 and the disclosed technological variations, a person of ordinary skill in the art would find the claimed neuromorphic electrical stimulation systems and methods to be obvious variations of existing electrical stimulation therapy technologies. The incremental computational and adaptive enhancements represent predictable applications of known techniques in medical device design, thereby rendering potential patent claims obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent Number	US 11,857,785
Title	Systems, methods and devices for electrical stimulation therapy
Assignee(s)	Theragen, Inc.